["Heterogeneity/NN of/IN autoimmune/JJ diseases/NNS :/: pathophysiologic/NN insights/NNS from/IN genetics/NNS and/CC implication/NN for/IN new/JJ therapies/NNS ./.", "TABLE/NN 5/CD Target/NNP Particle/NNP Formulation/NNP 6/CD (/( wt/CD %/NN )/) 10.9/CD 16.5/CD 10.6/CD 43.3/CD 18.7/CD 1OOO/CD Approximate/NNP Solid/NNP Ratio/NNP 1.O/CD 1.6/CD 1.O/CD 4.1/CD 1.8/CD Component/NNP Sodium/NNP Citrate/NNP Citric/NNP Acid/NNP Methionine/NNP oxyntomodulin/MD SUCOSE/NNP total/JJ */NNP Sodium/NNP Citratefitric/NNP Acid/NNP formed/VBD the/DT citrate/NN buffer/NN for/IN this/DT particle/NN formulation/NN ./.", "Additional/JJ reactants/NNS ,/, including/VBG other/JJ combinations/NNS of/IN acids/NNS and/CC bases/NNS which/WDT produce/VBP an/DT inert/NN gas/NN by/IN product/NN are/VBP also/RB contemplated/VBN ./."]